Showing 641 - 660 results of 100,166 for search '(( 5 ((ht decrease) OR (mean decrease)) ) OR ( 5 ((a decrease) OR (nn decrease)) ))', query time: 1.73s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644

    5-HT treatment modulates TGFβ3 mediated gene expression. by Philip R. Buskohl (146307)

    Published 2012
    “…<p><b>A</b>) TGFβ3 mRNA transcripts increase with physiological 5-HT (470 nM, <i>5-HT</i>), but decrease at high dose (47 µM, <i>5-HT+</i>). αSMA, RhoA, and col1α2, were not affected by physiological 5-HT dose, but were significantly downregulated with high 5-HT treatment. …”
  5. 645
  6. 646
  7. 647
  8. 648
  9. 649

    Myoendothelial and/or endothelial gap junctions participate to the calcium and contractile responses to 5-HT. by Marie Billaud (261506)

    Published 2009
    “…<p>Typical traces of simultaneous recordings of intracellular calcium (top panel) and contraction (bottom panel) induced by 5­HT 10 µM are shown in A. 300 µM <sup>37-43</sup>Gap 27 was introduced into the bath where indicated. …”
  10. 650
  11. 651
  12. 652

    Tau phosphorylation is decreased in neurons treated with 20 mM KCl. by Nguyen-Vi Mohamed (323606)

    Published 2017
    “…The phosphorylation of S199/S202, T181, T205 and S404 was not significantly affected by 10mM of KCl treatment whereas the phosphorylation of all these sites was decreased by 20mM of KCl treatment. The signal of the phospho-antibodies was normalized to that of total Tau (n = 5, mean ± SEM, unpaired t-test two-tailed, *<i>P</i> < 0.05, ***<i>P</i> < 0.001). …”
  13. 653
  14. 654
  15. 655
  16. 656

    Genetic deletion of P2rx7 leads to the alteration of NA and 5-HT levels (A, B), elevation of<sup>3</sup>H-Citalopram binding sites and 5-HT uptake (C) in the mouse hippocampus. by Cecilia Csölle (425362)

    Published 2013
    “…<p>A, B/NA and 5-HT levels were analyzed using HPLC in the hippocampus of naive and LPS (1 mg/kg)-treated P2rx7+/+ and P2rx7−/− mice. …”
  17. 657
  18. 658
  19. 659

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  20. 660